| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 15.980 | 80.334 | 149.789 | 137.376 | 146.837 | 211.779 | 176.117 | 79.844 |
| Total Income - EUR | - | - | 15.980 | 80.334 | 157.985 | 142.577 | 147.828 | 212.395 | 179.655 | 89.274 |
| Total Expenses - EUR | - | - | 2.139 | 65.732 | 150.698 | 160.865 | 144.170 | 186.442 | 165.751 | 72.838 |
| Gross Profit/Loss - EUR | - | - | 13.841 | 14.602 | 7.286 | -18.288 | 3.657 | 25.953 | 13.904 | 16.436 |
| Net Profit/Loss - EUR | - | - | 13.362 | 12.727 | 5.785 | -19.665 | 2.179 | 23.871 | 12.143 | 14.196 |
| Employees | - | - | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Pharmaone Bios Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 1.403 | 1.178 | 3.505 | 2.856 | 2.317 | 1.817 | 1.314 |
| Current Assets | - | - | 21.207 | 43.558 | 58.518 | 28.425 | 15.143 | 28.043 | 23.944 | 47.200 |
| Inventories | - | - | 5.107 | 4.796 | 22.965 | 7.871 | 6.295 | 9.133 | 8.412 | 17.268 |
| Receivables | - | - | 15.980 | 3.463 | 14.595 | 10.006 | 3.628 | 4.334 | 1.388 | 13.386 |
| Cash | - | - | 120 | 35.299 | 20.957 | 10.548 | 5.220 | 14.577 | 14.144 | 16.546 |
| Shareholders Funds | - | - | 13.406 | 17.420 | 5.827 | -13.949 | -11.460 | 12.375 | 12.184 | 26.312 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 7.801 | 27.541 | 53.868 | 45.879 | 29.459 | 17.986 | 13.577 | 22.202 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Pharmaone Bios Srl